Monday, October 26, 2026 · Daily editionET --:--:--

Finished

CorPath® GRX Neuro Study

NCT04236856 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 6 March 2025

What is being tested
Robotic Endovascular Procedure
For
Intracranial Aneurysm; Subarachnoid Hemorrhage; Headache
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 120 people. The full rules are on the registry page.
Where
Australia, Austria, Canada, France, Spain, Switzerland (10 sites)
When
Starts or started 21 Aug 2020, ends 12 Oct 2022. Registered 22 Jan 2020.
Results
Posted on the registry on 6 March 2025.

In the researchers' words

The primary objective of this study is to evaluate the effectiveness and safety of robotic-assisted endovascular embolization procedures compared to objective performance criteria for traditional, manual operation based on the scientific literature.
ClinicalTrials.gov, NCT04236856

Sites

  • Gold Coast University HospitalSouthport, Queensland, Australia
  • Uniklinikum SalzburgSalzburg, Austria
  • Toronto Western HospitalToronto, Ontario, Canada
  • St. Michael's HospitalToronto, Canada
  • Hôpital Pitié-SalpêtrièreParis, CA, France
  • CHU Montpellier - Hôpital Gui de ChauliacMontpellier, France
  • Hôpital de la Fondation RothschildParis, France
  • Vall d'Hebron University HospitalBarcelona, Spain
  • University Clinical Hospital of ValladolidValladolid, Spain
  • Inselspital, Universitätsspital BernBern, Switzerland